SSY Group Limited
Research SSY Group Limited (2005.HK) on Bullrun: market cap HKD 7.90B, P/E 16.2, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2005.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 7.90B
- P/E16.2
- Dividend yield3.2%
- Financial periodFY2025
- RevenueHKD 4.17B
- Revenue growth-27.8%
- Net incomeHKD 470.64M
- Free cash flowHKD 299.78M
- Gross margin41.6%
Valuation Snapshot
latest market cap is HKD 7.90B; P/E is 16.2; dividend yield is 3.2%.
Peer valuation comparison
Latest P/E is 16.18x versus a Healthcare sector median of 21.69x (25.4% below).
Latest dividend yield is 3.17% versus a Healthcare sector median of 2.41% (31.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 4.17B | HKD 470.64M | HKD 299.78M | 41.6% | n/a | HKD 1.69B | HKD 4.01B | HKD 7.30B |
| FY2024 | HKD 5.77B | HKD 1.06B | -HKD 49.39M | 50.4% | 0.36 | HKD 1.26B | HKD 3.64B | HKD 7.22B |
| FY2023 | HKD 6.46B | HKD 1.32B | HKD 221.88M | 56.0% | 0.44 | HKD 1.62B | HKD 3.37B | HKD 6.93B |
| FY2022 | HKD 6.43B | HKD 1.12B | HKD 315.57M | 55.4% | 0.38 | HKD 1.67B | HKD 3.21B | HKD 6.21B |
| FY2021 | n/a | n/a | n/a | n/a | 0.26 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 7.90B | 16.2 | 3.1% | 0.09 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.09 HKD, yield 3.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.15 HKD |
| FY2024 | 0.18 HKD |
| FY2023 | 0.15 HKD |
| FY2022 | 0.13 HKD |
| FY2021 | 0.1 HKD |
About SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SSY Group Limited's market cap?
SSY Group Limited's market capitalization is HKD 7.90B.
What is SSY Group Limited's P/E ratio?
SSY Group Limited's price-to-earnings (P/E) ratio is 16.2.
Does SSY Group Limited pay a dividend?
SSY Group Limited has a dividend yield of 3.2%.
What does SSY Group Limited do?
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials.